Literature DB >> 11814652

Vanilloid receptor type 1-immunoreactivity is expressed by intrinsic afferent neurones in the guinea-pig myenteric plexus.

Sharon Anavi-Goffer1, Neil G McKay, Michael L J Ashford, Angela A Coutts.   

Abstract

The enteric sensory nervous system consists of extrinsic and intrinsic components. The cellular distribution of vanilloid receptor type 1 (VR1) and its relation to the intrinsic sensory neurones were studied in myenteric plexus-longitudinal muscle preparations of rat ileum and guinea-pig ileum and colon. VR1-immunoreactivity was localized on fine fibres and expressed by ganglionic cells. In the guinea-pig myenteric plexus, a proportion of VR1-immunoreactive cells co-localized with calbindin, a marker for intrinsic afferent neurones. Reverse transcription-polymerase chain reaction with rat VR1-specific primers detected VR1 mRNA in rat but not in guinea-pig preparations. We conclude that VR1 is expressed on fibres and by myenteric neurones. In the guinea-pig, VR1 is expressed by intrinsic afferent neurones but its mRNA may differ from the rat sequence in the region of the primers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814652     DOI: 10.1016/s0304-3940(01)02480-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.

Authors:  Inés M Poblete; María Luz Orliac; René Briones; Edda Adler-Graschinsky; J Pablo Huidobro-Toro
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

2.  Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Authors:  R Makwana; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

3.  Extrinsic Primary Afferent Neurons Link Visceral Pain to Colon Motility Through a Spinal Reflex in Mice.

Authors:  Kristen M Smith-Edwards; Sarah A Najjar; Brian S Edwards; Marthe J Howard; Kathryn M Albers; Brian M Davis
Journal:  Gastroenterology       Date:  2019-05-08       Impact factor: 22.682

4.  The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Authors:  A Miranda; E Nordstrom; A Mannem; C Smith; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2007-08-23       Impact factor: 3.590

5.  Transient receptor potential vanilloid type 1 channel (TRPV1) immunolocalization in the murine enteric nervous system is affected by the targeted C-terminal epitope of the applied antibody.

Authors:  Roeland Buckinx; Luc Van Nassauw; Leela R Avula; Katrien Alpaerts; Dirk Adriaensen; Jean-Pierre Timmermans
Journal:  J Histochem Cytochem       Date:  2013-03-12       Impact factor: 2.479

6.  Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles.

Authors:  József Kun; István Szitter; Agnes Kemény; Anikó Perkecz; László Kereskai; Krisztina Pohóczky; Aron Vincze; Szilárd Gódi; Imre Szabó; János Szolcsányi; Erika Pintér; Zsuzsanna Helyes
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Transient receptor potential vanilloid 1-immunoreactive signals in murine enteric glial cells.

Authors:  Masahiro Yamamoto; Mitsue Nishiyama; Seiichi Iizuka; Shigeaki Suzuki; Norihiro Suzuki; Sadakazu Aiso; Jin Nakahara
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

8.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

9.  Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

Authors:  Jeremias Motte; Björn Ambrosius; Thomas Grüter; Hussein Bachir; Melissa Sgodzai; Xiomara Pedreiturria; Kalliopi Pitarokoili; Ralf Gold
Journal:  J Neuroinflammation       Date:  2018-04-24       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.